mitochondria, including loss of mitochondrial transmembrane A variety of key events in the molecular apoptotic pathway potential, activation of the mitochondrial permeability transinvolve the mitochondria. Cyclosporin A (csA) affects the ition (MPT), the participation of bcl-2 family proteins and the mitochondria by inhibiting the mitochondrial permeability release of caspase activators. If a mechanism for commitment transition (MPT), thereby preventing disruption of the to cell death exists, it may involve these mitochondrial events. transmembrane potential. The role of the MPT in apoptosis Cytochrome c (cyt c) is released from the mitochondrial is not fully understood, but inhibition of the MPT may intermembrane space to the cytosol where it forms a complex prevent the release of mitochondrial caspase activators, with Apaf-1 and caspase-9, thereby triggering caspase-9 activasuch as cytochrome c (cyt c), into the cytosol. Certain tion and initiating the caspase cascade (5-7). It has been hexavalent chromium [Cr(VI)] compounds are known occusuggested that cyt c release may occur in response to a collapse pational respiratory tract toxins and carcinogens. We have of the mitochondrial inner transmembrane potential (3). The previously shown that these compounds induce apoptosis loss of membrane potential indicates a MPT caused by opening as a predominant mode of cell death and that this effect of a large conductance MPT pore (8) . Studies with isolated can be observed in cell culture using soluble Cr(VI).
mitochondria show that the MPT pore favors a closed state, We show here that Cr(VI)-induced apoptosis in Chinese but certain physiological and pathological signals trigger pore hamster ovary (CHO) cells involves disruption of mitochonopening (9-11). The fully opened state creates a channel for drial stability. Using a cyt c-specific monoclonal antibody, ഛ1.5 kDa molecules, resulting in dissipation of the H ϩ gradient we observed a dose-dependent release of mitochondrial cyt across the membrane and uncoupling of the respiratory chain c in cytosolic extracts of CHO cells exposed to apoptogenic (12) . Two models have been established which describe how doses of sodium chromate. Co-treatment of these cells with MPT pore opening may effect cyt c release. In the first model, csA inhibited the release of cyt c and abrogated Cr(VI)-opening of the MPT pore may result in mitochondrial volume induced apoptosis as determined by a reduction in interexpansion, eventually causing outer membrane rupture and nucleosomal DNA fragmentation. Co-treatment with csA thereby releasing intermembrane caspase-activating proteins, also markedly increased clonogenic survival of Cr(VI)-such as cyt c. The alternative model suggests that the MPT treated CHO cells. In contrast, the general caspase inhibitor may trigger a signal for the opening of an outer membrane Z-VAD-FMK markedly inhibited most of the morphological channel which allows cyt c release without concomitant and biochemical parameters of apoptosis but did not organellar swelling. Cyclosporin A (CsA), an immunoprevent cyt c release and did not increase clonogenic suppressant, can inhibit the MPT. CsA binds to Cyp-M, a survival. These results suggest that the MPT plays an cyclophilin-family protein associated with the MPT pore, important role in the regulation of mitochondrial cyt c causing it to dissociate from the pore complex (13, 14) . This release and that this may be a critical point in the apoptotic reaction is believed to increase the probability of pore closure. pathway in which cells are irreversibly committed to death.
In this study we have examined whether csA can block apoptosis and restore clonogenic survival to cells exposed to apoptogenic doses of hexavalent chromium [Cr(VI)].
Introduction
Exposure to particulate Cr(VI) is strongly associated with The apoptotic signaling pathway consists of a cascade of lung toxicity and increased incidence of lung cancer (15,16). molecular events which lead from the initiation of cell death Soluble sodium chromate (Na 2 CrO 4 ) can be used to study the to eventual dismantling of the cell. The point at which the cell effects of Cr(VI) in culture. Cr(VI) is transported into cells is irrevocably committed to death is unclear. Inhibitors of the where it undergoes metabolic reduction to reactive genotoxic species (17) (18) (19) The secondary probe was detected by using the Renaissance enhanced chemiluminescence detection system (NEN, Boston, MA).
Materials and methods

Integrated density analysis Cell culture
Relative densities of protein or DNA bands were determined using an Eagle CHO AA8 cells were maintained in Eagle's basal medium containing 10%
Eye II still video imaging system with Eaglesight software (Stratagene). fetal bovine serum (Hyclone Laboratories, Logan, UT), 100 U/ml penicillin, Clonogenicity analysis 100 µg/ml streptomycin (Life Technologies, Gaithersburg, MD) and 2 mM glutamine (Life Technologies) in a 95% air/5% CO 2 humidified atmosphere CHO cells were seeded at 10 5 cells/60 mm 2 dish and incubated for 24 h prior at 37°C.
to csA or Z-VAD-FMK treatment and Na 2 CrO 4 exposure. After the 24 h exposure, cells were collected by trypsinization, counted, and reseeded at Treatment of cells with chromium, Z-VAD-FMK and csA 2ϫ10 2 cells/60 mm 2 dish in triplicate. The plates were incubated for 9-10 Sodium chromate (Na 2 CrO 4 ·4H 2 O) (J.T. Baker Chemical Co., Phillipsburg, days, then rinsed with PBS and incubated with crystal violet stain (80% NJ) was dissolved in double distilled H 2 O and sterilized through a 0.2 µm methanol, 2% formaldehyde, 2.5 g/l crystal violet) for 15-30 min at room filter before use. Cells were treated with a final concentration of 0, 3, 6, 9 or temperature. The plates were thoroughly rinsed with dH 2 O and allowed to 12 µM Na 2 CrO 4 for 24 h in complete medium. After 24 h the medium was dry. Colonies were counted, the triplicates were averaged and long-term replaced and the cells were incubated for an additional 24 h period. csA survival was determined as a percent of control. (Sigma, St Louis. MO) was dissolved in dimethyl sulfoxide (DMSO). Cells
Cr uptake analysis were pre-treated for 30 min prior to the Na 2 CrO 4 exposure and co-treated for the 24 h Na 2 CrO 4 exposure period with a final concentration of 5 µM Conical tubes (15 ml) containing 5ϫ10 5 CHO cells/sample were pre-treated csA. Z-Val-Ala-Asp(OMe)-FMK (Z-VAD-FMK) (Enzyme Systems Products, with either 5 µM csA or an equivalent volume of DMSO (final concentration Livermore, CA) was dissolved in DMSO and added to cells immediately prior 0.1%) for 30 min at 37°C. The cells were then exposed to appropriate to the 24 h Na 2 CrO 4 exposure period at a final concentration of 50 µM. The concentrations of Na 2 CrO 4 spiked with Na 2 51 CrO 4 for 3 h at 37°C. The cells final concentration of DMSO in the medium never exceeded 0.1%. Control were centrifuged at 300 ϫ g for 5 min at 4°C. Cell pellets were washed twice samples were exposed to an equivalent concentration of DMSO.
in PBS and lysed in 500 µl lysis buffer (100 mM Tris-HCl, pH 8.0, 200 mM NaCl, 10 mM EDTA, 4% SDS). An aliquot of 100 µl of each sample was Internucleosomal DNA fragmentation (IDF) analysis transferred to a 5 ml scintillation vial and combined with 1 ml of Ecolite IDF was analyzed after the 24 h post-Na 2 CrO 4 exposure period. Cells were scintillation cocktail (ICN, Irvine, CA). Values for d.p.m./10 5 cells were collected by trypsinization and combined with non-adherent cells from the determined in a Beckman LS6500 scintillation counter (Beckman Instruments, culture medium. The cells were centrifuged at 600 ϫ g for 5 min. Cell pellets Fullerton, CA). were washed once in phosphate-buffered saline (PBS) and lysed in 500 µl of digestion buffer (100 mM Tris-HCl, pH 8.0, 200 mM NaCl, 10 mM EDTA, 4% SDS and 0.2 mg/ml proteinase K), followed by incubation at 55°C for 18 clonogenicity following Cr(VI) exposure (32) . We isolated the non-adherent cells from the culture medium. The cells were centrifuged at cytosolic fractions using a method based on selective plasma 300 ϫ g for 5 min at 4°C and washed once with ice-cold PBS. Cell pellets were resuspended at 1.0-2.0ϫ10 7 cells/ml in ice-cold isotonic cytosol buffer membrane permeabilization in isotonic buffer containing low [210 mM mannitol, 70 mM sucrose, 5 mM HEPES, pH 7.5, 0.2 mM EGTA, 1 concentrations of digitonin (33, 34) . This method allows isolamM MgCl 2 , 5 mM glutamic acid, 5 mM malate, 0.1 mM phenylmethylsulfonyl tion of cytosol without contamination with mitochondriafluoride, supplemented with protease inhibitors (5 µg/ml pepstatin A, 10 µg/ associated cyt c. We carefully titrated the level of digitonin ml leupeptin, 2 µg/ml aprotonin) (Sigma), and containing.004% digitonin to used in the isotonic cytosol buffer to determine the optimal permeabilize the cells]. Cell suspensions were stirred for 10 min and then centrifuged at 12 000 ϫ g for 15 min at 4°C to remove cell membrane conditions for plasma membrane permeability without mitodebris, mitochondria and other organelles. The resulting supernatants were chondrial membrane permeability in CHO cells. We observed concentrated through Millipore Ultrafree-CL filters and stored at -20°C until that a 24 h exposure to different concentrations of Na 2 CrO 4 used for PAGE and western blot analysis.
caused a dose-dependent increase in cytosolic levels of cyt c
For measurement of the full cyt c content of a cellular sample, cytoplasmic extracts were isolated in a hypotonic solution. This cell fraction contains lysed ( Figure 1A ). Densitometric analysis of independent western blots showed that at the 3 µM dose only a minor increase in cytosolic cyt c was observed ( Figure 1B) . However, the cytosolic cyt c levels increased as the Na 2 CrO 4 dose increased from 3 to 12 µM. The increases in cytosolic cyt c levels were statistically significant by Student's t-test at the 6, 9 and 12 µM Na 2 CrO 4 doses (P ϭ 0.024, 2.3ϫ10 -7 and 7.4ϫ10 -4 , respectively). cyt c release was maximal at the highest dose tested (12 µM), which corresponds to nearly 100% apoptotic cell death in CHO cells (data not shown). Cytosolic samples with the full mitochondrial cyt c content isolated using a hypotonic buffer were also analyzed. The level of cyt c release at the 12 µM dose was~75% of the total cyt c content of the induced IDF, verifying the dependence for IDF on caspase activity. Treatment with 5 µM csA was also able to reduce IDF induced by 9 µM Na 2 CrO 4 , indicating that cyt c release may also be a necessary component of the IDF pathway. Densitometric analysis of three independent IDF gels showed that Z-VAD-FMK is able to reduce the amount of IDF to 36% of that caused by 9 µM Na 2 CrO 4 alone, while csA can reduce Cr-induced IDF to a comparable 41% ( Figure 3B) .
Since csA was shown to block mitochondrial cyt c release and reduce apoptosis, we examined whether it could restore clonogenic survival to Cr-treated CHO cells. Clonogenicity is an indicator of a cell's long-term survival and ability to grow and form colonies in culture after exposure to a toxic agent. Clonogenicity reflects both apoptosis and long-term growth arrest caused by the toxic exposure. The clonogenicity of CHO cells exposed to different concentrations of Na 2 CrO 4 alone and with pre-and co-treatments with csA or Z-VAD-FMK was determined (Figure 4) . At the 3 and 6 µM doses csA was able to increase the number of colonies that formed. The increase in clonogenicity was statistically significant by StuGenomic DNA was isolated from CHO cells exposed to 0 or 9 µM dent's t-test at the 3 and 6 µM Na 2 CrO 4 doses (P ϭ 0.021 Na 2 CrO 4 for 24 h, and either treated with 5 µM csA, 50 µM Z-VAD-FMK and 0.003, respectively). Exposure to 3 µM Na 2 CrO 4 decreased or a solvent control. The DNA was isolated 24 h after exposure and clonogenic survival to 57% compared with the 0 µM control. increased this clonogenic potential to 30%. We observed the same trend at the highly toxic 9 µM dose, although it was not statistically significant. In contrast, Z-VAD-FMK had no effect fragments is a hallmark indicator of apoptosis (35). IDF is considered a late stage apoptotic event and is induced by on clonogenicity of Cr-exposed CHO cells. Because csA, but not Z-VAD-FMK, increased clonogenic active caspases (36) . CHO cells exposed to 9 µM Na 2 CrO 4 undergo extensive IDF ( Figure 3A) . Inhibition of the caspases survival after chromium treatment, we sought to determine whether csA affected uptake of Cr(VI) from the medium. with 50 µM Z-VAD-FMK was able to markedly reduce Cr-Exposure to apoptotic doses of Cr(VI) causes mitochondrial instability, as indicated by the release of cyt c into the cytosol (Figure 1 ). It is believed that cyt c release is necessary for activation of the caspase cascade or, in some cases, at least for the amplification of caspase activity required for a normal apoptotic response (6, 7, 12 ). Here we show that treatment with the caspase inhibitor Z-VAD-FMK is able to inhibit DNA fragmentation associated with apoptosis ( Figure 3 ) but does not affect long-term clonogenic survival (Figure 4) . Despite inhibition of the morphological apoptotic characteristics caused by active caspases, the cells never regain replicative competency and eventually die. The point at which a cell is committed to death should, therefore, occur upstream of the caspase cascade.
csA functions at the mitochondria by promoting mitochondrial stability and preventing the release of caspase activators. It is believed to bind at the MPT pore, thereby increasing the probability of pore closure and preventing disruption of the mitochondrial inner membrane potential (13, 14) . Our results indicate that treatment with csA is able to inhibit apoptosis ( Figure 3 ) and block mitochondrial cyt c release ( Figure 2 ). Most importantly, csA treatment is able to restore long-term clonogenic survival to cells that have been exposed to apoptotic It is unclear whether the 'point of no return' in cell death is disruption of the mitochondrial membrane potential or release of mitochondrial caspase activators. These two events may be Importantly, csA did not alter Cr uptake by CHO cells (Figure  intricately linked, however, some studies have shown that the 5). CHO cells treated with csA and exposed to different levels release of cyt c can occur before or in the absence of disruption of Na 2 51 CrO 4 for 3 h had similar levels of intracellular 51 Cr of the transmembrane potential (37,38). It is possible that to the solvent controls. different regulatory events which control mitochondrial membrane permeability are dependent on cell type. Nevertheless, Discussion it seems likely that uncoupling of the respiratory chain and Dysregulation of the homeostasis between cell proliferation subsequent release of cyt c from the mitochondria would and cell death is involved in a vast array of human health prevent long-term cell survival. Release of cyt c from a consequences, including tumorigenesis. If apoptosis fails to mitochondrion should cause an irreversible disruption of oxidoccur normally when cells have been damaged or injured, then ative phosphorylation, rendering the mitochondrion non-funcit may contribute to the progression of cancer. In studying tional for energy metabolism and cell growth. The extent of the relationship between apoptosis and cancer, genotoxic cyt c release may vary for each cell depending on the individual carcinogens are particularly interesting because in order to molecular and cellular factors that govern apoptosis. Thus it induce neoplastic transformation, doses that induce a certain is possible that when a critical amount of cyt c is released level of apoptosis are often required (16). In the case of from mitochondria the cell is committed to death, either Cr(VI), exposure to levels of particulate Cr compounds that apoptotic or otherwise. are associated with lung cancer usually also cause respiratory At lower doses (3 µM) of Cr(VI) only a small amount of toxicity that manifests as perforation of the nasal septum and/ cyt c release (reproducible but not statistically significant) or respiratory tract ulcerations (16). These conditions are could be observed at one particular time point (Figure 1 ). associated with high levels of cell death, thus a key question Interestingly, these low doses caused a significant decrease in is how and why do certain cells exposed to a carcinogen clonogenic survival (57% of control) over a longer course of escape death when others die? In tissue exposed to a Cr(VI) time. Cyt c release at lower doses of Cr(VI) may occur compound, individual cells may experience different local gradually followed by a protracted increase in apoptosis. concentrations that are possibly genotoxic but not apoptotic.
Therefore, this response accounts for the significant decrease The populations of cells which either escape or are resistant in clonogenic survival, but a marked release of cyt c at any to apoptosis may become the precursor pools out of which one moment in time would not be expected. Nevertheless, neoplastic variants will emerge. Therefore, it is important to treatment with csA was able to significantly increase the longdetermine the point in the apoptotic pathway when a cell is term survival of the cells, raising clonogenicity from 57 to irrevocably committed to death. Our results here suggest that nearly 100% (Figure 4) . csA was not able to significantly the 'point of no return' for chromium-induced apoptosis occurs increase the clonogenic survival of cells treated with the at the mitochondria and that cells that survive an apoptotic highest dose of Cr(VI) (9 µM). This is undoubtedly due to the challenge may have a selective advantage in their ability to maintain mitochondrial stability.
presence of an insurmountable amount of damage to critical
